Timing of administration : Taking tirzepatide at a consistent time each week, preferably when patients can rest if needed, may improve tolerability
In OA models, ACSL4 inhibition dramatically decreases ferroptosis-associated lipid peroxidation ( in vitro models, inhibiting cartilage chondroptosis and improving OA ( Excessive lipid metabolic reprogramming in OA significantly raises ferroptosis risk, so targeting lipid synthesis, transport, and degradation represents a promising upstream approach to reducing ferroptotic damage
doi: 10.3389/fendo.2022.886451 21 ArikanTA
Guasch-Ferr M, Hruby A, Toledo E, Clish CB, Martnez-Gonzlez MA, Salas-Salvad J, et al
Species differences in the distribution of drug-metabolizing enzymes in the pancreas